AFFINITY INVESTMENT ADVISORS, LLC CVS CVS HEALTH CORP

Ownership history in AFFINITY INVESTMENT ADVISORS, LLC  ·  37 quarters on record

AI Ownership Summary

AFFINITY INVESTMENT ADVISORS, LLC reported CVS HEALTH CORP (CVS) in 37 quarterly 13F filings from 2023 Q4 through 2026 Q1. Peak portfolio weight reached 1.6% in 2024 Q1. The latest visible filing shows CVS at 1.07% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this CVS ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was AFFINITY INVESTMENT ADVISORS, LLC's position in CVS HEALTH CORP, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

CVS was reported at 1.07% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
1.6% in 2024 Q1

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q4 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How AFFINITY INVESTMENT ADVISORS, LLC held CVS — position size vs. price
% of Fund (quarterly)    CVS price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 10 quarters  
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 ADDED 23,780 +2,272 +10.6% 1.07% $1.7M 2026-05-14 $97.15
2025 Q4 REDUCED 21,508 -108 -0.5% 1.13% $1.7M 2026-02-12 $77.25
2025 Q3 ADDED 21,616 +2,422 +12.6% 1.10% $1.6M 2025-11-10 $76.24
2025 Q2 ADDED 19,194 +11,062 +136.0% 1.00% $1.3M 2025-08-14 $65.08
2025 Q1 REDUCED 31.4% +2.9% 8,132 -3,722 -31.4% 0.45% $551K 2025-05-13 $58.37
2024 Q4 REDUCED 28.9% +52.8% 11,854 -4,816 -28.9% 0.44% $532K 2025-02-11 $52.52
2024 Q3 REDUCED 32.9% -29.4% 16,670 -8,158 -32.9% 0.72% $1.0M 2024-10-28 $54.08
2024 Q2 REDUCED 9.5% +7.7% 24,828 -2,597 -9.5% 1.10% $1.5M 2024-08-13 $52.05
2024 Q1 ADDED 27,425 +291 +1.1% 1.60% $2.2M 2024-05-03 $51.54
2023 Q4 REDUCED 27,134 -1,177 -4.2% 1.46% $2.1M 2024-02-09 $69.70
27 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

FAQ About AFFINITY INVESTMENT ADVISORS, LLC and CVS

These are the practical questions this page is built to answer before you even open the full history table.

How long has AFFINITY INVESTMENT ADVISORS, LLC reported owning CVS?

AFFINITY INVESTMENT ADVISORS, LLC reported CVS across 10 quarterly 13F filings, from 2023 Q4 through 2026 Q1.

What was the largest reported CVS position in AFFINITY INVESTMENT ADVISORS, LLC's portfolio?

The largest reported portfolio weight for CVS was 1.60% in 2024 Q1.

What is the latest reported CVS position on this page?

The most recent filing on this page is 2026 Q1, when AFFINITY INVESTMENT ADVISORS, LLC reported 23,780 shares, equal to 1.07% of portfolio, with an estimated market value of $1.7M.

What does the chart on this CVS ownership page compare?

The chart compares AFFINITY INVESTMENT ADVISORS, LLC's quarterly CVS portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did AFFINITY INVESTMENT ADVISORS, LLC time their CVS position?

Based on 13F filing dates vs. subsequent CVS price moves, AFFINITY INVESTMENT ADVISORS, LLC correctly timed 15 out of 34 reported position changes (44%). The annualised alpha on CVS relative to SPY over the holding period was -10.1%.

← Back to AFFINITY INVESTMENT ADVISORS, LLC Holdings